Topical pharmacotherapy for skin cancer: part I. Pharmacology.
about
Interventions for preventing keratinocyte cancer in high-risk groups not receiving immunosuppressive therapyBasal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical TherapiesIngenol mebutate in low amounts for the treatment of actinic keratosis in Korean patients.The effect of wool hydrolysates on squamous cell carcinoma cells in vitro. Possible implications for cancer treatment.Anti-cancer activity of ZnO chips by sustained zinc ion release.A new potential option for topical treatment of basal cell carcinoma?Factors influencing response to ingenol mebutate therapy for actinic keratosis of face and scalp.Updates on the Management of Non-Melanoma Skin Cancer (NMSC).Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity.Is inflammatory micronucleation the key to a successful anti-mitotic cancer drug?Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapy.Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers.Ingenol mebutate gel for the treatment of Bowen's disease: a case report of three patients.Rapidly-growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases.Regulation of bone regeneration with approved small molecule compounds
P2860
Q26471604-29B3D685-8557-4E23-B1F1-8A0EDB0285F5Q26744173-18085902-16D1-4659-938B-0E1FAF916996Q37741996-E0F2BE25-D23A-4D18-9EFA-058799F2D357Q38599730-ADC78C07-B09B-4316-AB21-8E79DAAFFEE6Q41679502-3C708A66-86B2-404C-BCE0-F3D84A5DDC57Q42512716-715F7687-1EE3-47F3-A8FE-745C872D89F2Q42702936-FAD3A328-B9D2-4D8F-9BE2-32AB020CFA0BQ46811811-BB7647D0-9324-445B-8705-DC921C54A274Q47101495-A99747CC-1A47-4B61-986F-0825FE785811Q47149120-519D080B-DC15-4DAF-B340-87B954313E06Q51736282-9DB7626B-CDE5-4067-85CE-ED22F8099F27Q52742485-3BBC63FC-2BD6-4BB0-8CF5-DA22B0E68BCFQ53150106-962347FC-AA02-4018-BF68-5660C5AFFE2DQ53400754-8461D6A4-F494-4419-A868-0DF340D2E17BQ58272176-44E45827-A66A-4BFE-A823-A84C74FA2A4C
P2860
Topical pharmacotherapy for skin cancer: part I. Pharmacology.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Topical pharmacotherapy for skin cancer: part I. Pharmacology.
@en
type
label
Topical pharmacotherapy for skin cancer: part I. Pharmacology.
@en
prefLabel
Topical pharmacotherapy for skin cancer: part I. Pharmacology.
@en
P2093
P1476
Topical pharmacotherapy for skin cancer: part I. Pharmacology.
@en
P2093
Francesco Lacarrubba
Giuseppe Micali
Maria Rita Nasca
Robert A Schwartz
P304
965.e1-12; quiz 977-8
P356
10.1016/J.JAAD.2013.12.045
P407
P577
2014-06-01T00:00:00Z